Ni Shu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ni Shu has a total of 270 co-authors. Here are the top co-authors by number of shared publications:
Weijie Huang
College of Artificial Intelligence, Nanjing University of Aeronautics and Astronautics, the Key Laboratory of Brain-Machine Intelligence Technology, Ministry of Education, Nanjing, China
21 shared publicationsHaojie Chen
State Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University, Beijing, China
14 shared publications- Weijie Huang
College of Artificial Intelligence, Nanjing University of Aeronautics and Astronautics, the Key Laboratory of Brain-Machine Intelligence Technology, Ministry of Education, Nanjing, China.
13 shared publications Guolin Ma
China-Japan Friendship Hospital (Institute of Clinical Medical Sciences), Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
12 shared publications- Guozheng Feng
State Key Laboratory of Cognitive Neuroscience and Learning & IDG/McGovern Institute for Brain Research, Beijing Normal University, Beijing, China
12 shared publications - Ying Han
Department of Neurology, XuanWu Hospital of Capital Medical University, Beijing, 100053, China
10 shared publications
Latest Publications
- Open Access
Human brain white matter charts in international populations
Brain charts provide normative references for identifying neurodevelopmental milestones and clinically meaningful deviations. Existing white matter (WM) charts are derived predominantly from European and North American populations, limiting generalizability. Here, we established the first set of population-specific WM charts of 198 morphological and microstructural phenotypes for both Chinese (N=19,215) and Western (N=15,584) populations across the human lifespan. Developmental trajectories and spatial organization of WM maturation and degeneration were broadly conserved across the populations, whereas maturational timing varied across pathways and metrics. The Chinese population showed earlier maturation in several projection and sensorimotor pathways, but more protracted maturation in higher-order association and limbic pathways. Chinese population-matched charts more accurately predicted WM phenotypes and detected more extreme disease-related deviations in brain health in the Chinese population than Western-derived models. Individual deviation patterns further discriminated patients from healthy controls and predicted cognitive performance and plasma biomarkers. Our findings reveal population-specific WM maturation and show that reference-population mismatch can reduce the accuracy and clinical sensitivity of normative brain charts.
Open AccessHuman brain white matter charts in international populations
Brain charts provide normative references for identifying neurodevelopmental milestones and clinically meaningful deviations. Existing white matter (WM) charts are derived predominantly from European and North American populations, limiting generalizability. Here, we established the first set of population-specific WM charts of 198 morphological and microstructural phenotypes for both Chinese (N=19,215) and Western (N=15,584) populations across the human lifespan. Developmental trajectories and spatial organization of WM maturation and degeneration were broadly conserved across the populations, whereas maturational timing varied across pathways and metrics. The Chinese population showed earlier maturation in several projection and sensorimotor pathways, but more protracted maturation in higher-order association and limbic pathways. Chinese population-matched charts more accurately predicted WM phenotypes and detected more extreme disease-related deviations in brain health in the Chinese population than Western-derived models. Individual deviation patterns further discriminated patients from healthy controls and predicted cognitive performance and plasma biomarkers. Our findings reveal population-specific WM maturation and show that reference-population mismatch can reduce the accuracy and clinical sensitivity of normative brain charts.
- Open Access
- 15 October 2026
- Published by Springer Nature in Research Square
Glymphatic Dysfunction Coupled with Aberrant Distribution of Iron and Pathological proteins across AD Continuum
Alzheimer’s disease (AD) involves impaired glymphatic clearance and altered iron-related and macromolecular tissue composition, yet how these processes are interconnected across the disease continuum remains unclear. We developed a multimodal MRI framework integrating complementary glymphatic indices with paramagnetic (χpara) and diamagnetic (|χdia|) susceptibility measures across AD continuum. Multivariate partial least squares analysis identified cross-modal covariance patterns, followed by disease-stage analyses and pseudotime modeling to characterize their stage-related and pseudotemporal organization. Glymphatic and susceptibility measures showed coordinated associations at both regional and network levels, with prominent involvement of temporal, limbic, and subcortical regions. Disease-stage-related relationships were predominantly characterized by perivascular space (PVS)- and basal forebrain (BF)-related coupling with χpara and |χdia| in temporal and limbic regions, whereas network-level alterations were primarily associated with PVS. Pseudotemporal modeling revealed heterogeneous organization, with PVS-related regional patterns predominating earlier, BF-related regional patterns at intermediate positions, and selective network-level involvement later. These findings suggest that glymphatic dysfunction and altered tissue composition represent interconnected components of disrupted brain fluid-tissue homeostasis across the AD continuum.
- 15 October 2026
- Published by Springer Nature in Research Square
Open AccessGlymphatic Dysfunction Coupled with Aberrant Distribution of Iron and Pathological proteins across AD Continuum
Alzheimer’s disease (AD) involves impaired glymphatic clearance and altered iron-related and macromolecular tissue composition, yet how these processes are interconnected across the disease continuum remains unclear. We developed a multimodal MRI framework integrating complementary glymphatic indices with paramagnetic (χpara) and diamagnetic (|χdia|) susceptibility measures across AD continuum. Multivariate partial least squares analysis identified cross-modal covariance patterns, followed by disease-stage analyses and pseudotime modeling to characterize their stage-related and pseudotemporal organization. Glymphatic and susceptibility measures showed coordinated associations at both regional and network levels, with prominent involvement of temporal, limbic, and subcortical regions. Disease-stage-related relationships were predominantly characterized by perivascular space (PVS)- and basal forebrain (BF)-related coupling with χpara and |χdia| in temporal and limbic regions, whereas network-level alterations were primarily associated with PVS. Pseudotemporal modeling revealed heterogeneous organization, with PVS-related regional patterns predominating earlier, BF-related regional patterns at intermediate positions, and selective network-level involvement later. These findings suggest that glymphatic dysfunction and altered tissue composition represent interconnected components of disrupted brain fluid-tissue homeostasis across the AD continuum.
- Open Access
- 13 May 2026
- Published by Springer Nature in Translational Psychiatry
- Vol. 16 (1)
Functional system-specific brain aging across the Alzheimer’s disease continuum
Accelerated brain aging is implicated in Alzheimer’s disease (AD). However, the spatial heterogeneity of brain aging patterns across different functional systems along the AD continuum remains largely unexplored. We developed functional system-specific brain age models derived from structural magnetic resonance imaging in a healthy adult cohort (n = 22,672) and applied them to 1478 participants across the AD continuum. Using up to 6 years of retrospective longitudinal data before clinical AD conversion, we quantified predicted age differences (PADs) and their change rates, characterized heterogeneous brain aging trajectories, and examined their associations with AD biomarkers, cognitive performance, and clinical progression. Progressive mild cognitive impairment (MCI) individuals showed early PAD deviations in the default mode network and accelerated changes in attention and control networks. System-wise PAD dynamics mediated the effects of AD-related biomarkers on cognitive decline. Integrating PAD features can improve predictive accuracy of MCI-to-AD conversion (AUC = 0.95). Functional system-specific PADs can be sensitive biomarkers for early detection and monitoring of individualized AD risk.
- 13 May 2026
- Published by Springer Nature in Translational Psychiatry
- Vol. 16 (1)
Open AccessFunctional system-specific brain aging across the Alzheimer’s disease continuum
Accelerated brain aging is implicated in Alzheimer’s disease (AD). However, the spatial heterogeneity of brain aging patterns across different functional systems along the AD continuum remains largely unexplored. We developed functional system-specific brain age models derived from structural magnetic resonance imaging in a healthy adult cohort (n = 22,672) and applied them to 1478 participants across the AD continuum. Using up to 6 years of retrospective longitudinal data before clinical AD conversion, we quantified predicted age differences (PADs) and their change rates, characterized heterogeneous brain aging trajectories, and examined their associations with AD biomarkers, cognitive performance, and clinical progression. Progressive mild cognitive impairment (MCI) individuals showed early PAD deviations in the default mode network and accelerated changes in attention and control networks. System-wise PAD dynamics mediated the effects of AD-related biomarkers on cognitive decline. Integrating PAD features can improve predictive accuracy of MCI-to-AD conversion (AUC = 0.95). Functional system-specific PADs can be sensitive biomarkers for early detection and monitoring of individualized AD risk.
- Open Access
- 6 May 2026
- Published by Springer Nature in Communications Biology
- Vol. 9 (1)
Shared genetic architecture between the topology of brain white matter structural connectome and fluid intelligence
White matter (WM) connections support efficient interregional communication and form the structural basis of human fluid intelligence. However, the shared genetic architecture between WM structural connectome and fluid intelligence remains largely unknown. In this study, we analyzed diffusion-weighted MRI data from 26,655 UK Biobank participants to construct individual WM connectome and performed genome-wide association analyses on global and regional network topology. We identified 41 single nucleotide polymorphisms (SNPs) significantly associated with global efficiency and 45 SNPs linked to nodal efficiency. Genetic correlations with fluid intelligence were observed for 128 brain regions, with 44 and 3 regions sharing SNPs within chromosomes 6q21 and 3p21.1, respectively. Mendelian randomization revealed causal effects from WM connectome to fluid intelligence, particularly in the orbital and superior frontal gyrus. Finally, integrating polygenic scores with network efficiency improved the prediction of individual fluid intelligence. These findings highlight the genetic basis linking WM connectome topology and fluid intelligence, providing new insights into the neurogenetic underpinnings of fluid intelligence.
- 6 May 2026
- Published by Springer Nature in Communications Biology
- Vol. 9 (1)
Open AccessShared genetic architecture between the topology of brain white matter structural connectome and fluid intelligence
White matter (WM) connections support efficient interregional communication and form the structural basis of human fluid intelligence. However, the shared genetic architecture between WM structural connectome and fluid intelligence remains largely unknown. In this study, we analyzed diffusion-weighted MRI data from 26,655 UK Biobank participants to construct individual WM connectome and performed genome-wide association analyses on global and regional network topology. We identified 41 single nucleotide polymorphisms (SNPs) significantly associated with global efficiency and 45 SNPs linked to nodal efficiency. Genetic correlations with fluid intelligence were observed for 128 brain regions, with 44 and 3 regions sharing SNPs within chromosomes 6q21 and 3p21.1, respectively. Mendelian randomization revealed causal effects from WM connectome to fluid intelligence, particularly in the orbital and superior frontal gyrus. Finally, integrating polygenic scores with network efficiency improved the prediction of individual fluid intelligence. These findings highlight the genetic basis linking WM connectome topology and fluid intelligence, providing new insights into the neurogenetic underpinnings of fluid intelligence.
- Open Access
- 3 March 2026
- Published by Oxford University Press (OUP) in Brain Communications
- Vol. 8 (2)
Synergistic effects of cerebral small vessel disease burden and plasma phosphorylated tau 181 on white matter microstructure and cognition in a Chinese cohort
Cerebral small vessel disease (CSVD) burden and plasma biomarkers are both critically associated with white matter (WM) microstructural damage and cognitive decline. However, whether these factors interact synergistically to exacerbate brain degeneration and cognitive decline remains unclear. We included 375 Chinese participants from the Aging cohort at Nanjing Drum Tower Hospital: 144 with none CSVD, 103 with mild CSVD (CSVD-I), and 128 with moderate to severe CSVD (CSVD-II). All participants underwent comprehensive cognitive assessment, plasma biomarker quantification, and MRI scanning. Diffusion tensor imaging was used to evaluate WM microstructure. Interaction effects between CSVD burden and plasma biomarkers were analyzed, and path analyses were performed to explore how two factors synergistically influence WM tracts and cognitive impairment. We found significant interactions between phosphorylated tau 181 (p-tau181) and CSVD burden on the integrity of multiple WM tracts (PFDR181 on neurofilament light, as well as an indirect effect of the cingulum mediating the relationship between p-tau181 and cognition (ΔIE͞ = -0.108, 90% CI = [-0.25, -0.0302]). Our findings suggest that vascular and molecular pathologies synergistically contribute to WM integrity damage and cognitive impairment. Targeting both vascular and molecular factors may be crucial for developing effective interventions to mitigate cognitive decline in the elderly population.
- 3 March 2026
- Published by Oxford University Press (OUP) in Brain Communications
- Vol. 8 (2)
Open AccessSynergistic effects of cerebral small vessel disease burden and plasma phosphorylated tau 181 on white matter microstructure and cognition in a Chinese cohort
Cerebral small vessel disease (CSVD) burden and plasma biomarkers are both critically associated with white matter (WM) microstructural damage and cognitive decline. However, whether these factors interact synergistically to exacerbate brain degeneration and cognitive decline remains unclear. We included 375 Chinese participants from the Aging cohort at Nanjing Drum Tower Hospital: 144 with none CSVD, 103 with mild CSVD (CSVD-I), and 128 with moderate to severe CSVD (CSVD-II). All participants underwent comprehensive cognitive assessment, plasma biomarker quantification, and MRI scanning. Diffusion tensor imaging was used to evaluate WM microstructure. Interaction effects between CSVD burden and plasma biomarkers were analyzed, and path analyses were performed to explore how two factors synergistically influence WM tracts and cognitive impairment. We found significant interactions between phosphorylated tau 181 (p-tau181) and CSVD burden on the integrity of multiple WM tracts (PFDR181 on neurofilament light, as well as an indirect effect of the cingulum mediating the relationship between p-tau181 and cognition (ΔIE͞ = -0.108, 90% CI = [-0.25, -0.0302]). Our findings suggest that vascular and molecular pathologies synergistically contribute to WM integrity damage and cognitive impairment. Targeting both vascular and molecular factors may be crucial for developing effective interventions to mitigate cognitive decline in the elderly population.
- 4 February 2026
- Published by Springer Nature in Molecular Psychiatry
- Vol. 31 (6) , 3139-3153
Developmental changes of the white matter functional connectome
Emerging studies have consistently shown that blood-oxygenation-level-dependent signals within white matter (WM) appear to be related to neural activity. This recognition of WM functional signal has provided a great opportunity to investigate how the brain’s WM functionally evolves in youth as well as its relationship to developmental disorders. Using multimodal imaging data from 407 participants aged 8 to 22 years, we constructed the WM functional connectome (WMFC) as well as the WM structural connectome (WMSC). Our findings reveal a global three-stage reorganization process in WMFC characterized by a decreasing-increasing-decreasing pattern. Regional changes are marked by hierarchical development between primary networks and higher-order networks. In conjunction with the WMSC, we measured WM SC‒FC coupling, and found that coupling monotonically decreases with development. Treating these spatial patterns as phenotypes of WM function, we demonstrated significant regulation by neurotransmitter receptors and transcriptomic expression. Notably, WMFC significantly explained the heterogeneous regional vulnerability in neurodevelopmental disorders and outperformed the WMSC in predicting cognitive function. This study underscores the importance of investigating WM function in understanding the neural mechanisms of brain maturation and disorders.
- 4 February 2026
- Published by Springer Nature in Molecular Psychiatry
- Vol. 31 (6) , 3139-3153
Developmental changes of the white matter functional connectome
Emerging studies have consistently shown that blood-oxygenation-level-dependent signals within white matter (WM) appear to be related to neural activity. This recognition of WM functional signal has provided a great opportunity to investigate how the brain’s WM functionally evolves in youth as well as its relationship to developmental disorders. Using multimodal imaging data from 407 participants aged 8 to 22 years, we constructed the WM functional connectome (WMFC) as well as the WM structural connectome (WMSC). Our findings reveal a global three-stage reorganization process in WMFC characterized by a decreasing-increasing-decreasing pattern. Regional changes are marked by hierarchical development between primary networks and higher-order networks. In conjunction with the WMSC, we measured WM SC‒FC coupling, and found that coupling monotonically decreases with development. Treating these spatial patterns as phenotypes of WM function, we demonstrated significant regulation by neurotransmitter receptors and transcriptomic expression. Notably, WMFC significantly explained the heterogeneous regional vulnerability in neurodevelopmental disorders and outperformed the WMSC in predicting cognitive function. This study underscores the importance of investigating WM function in understanding the neural mechanisms of brain maturation and disorders.
- Open Access
- 23 October 2025
- Published by Elsevier in NeuroImage
- Vol. 322, 121550
Multimodal integration of plasma biomarkers, MRI, and genetic risk to predict cerebral amyloid burden in Alzheimer’s disease
- 23 October 2025
- Published by Elsevier in NeuroImage
- Vol. 322, 121550
Open AccessMultimodal integration of plasma biomarkers, MRI, and genetic risk to predict cerebral amyloid burden in Alzheimer’s disease
- Open Access
- 21 October 2025
- Published by Springer Nature in Genome Medicine
- Vol. 17 (1) , 1-14
Polygenic risk for Alzheimer’s disease in healthy aging: age-related and APOE-driven effects on brain structures and cognition
Alzheimer’s disease (AD) is characterized by progressive neurodegeneration and cognitive decline with age. The genetic architecture of AD involves multiple loci, including the apolipoprotein E gene (APOE). The polygenic risk scores for AD (AD-PRS) provide a comprehensive genome-wide assessment of AD risk, yet their age-related effects on brain structures and cognitive function in cognitively unimpaired individuals remain largely undefined. We analyzed cognitively unimpaired, genetically unrelated Caucasians from the UK Biobank (N = 21,236, 64.5 ± 7.6 years). AD-PRS was derived using a Bayesian approach incorporating approximately 5 million genetic variants (UK Biobank’s standard PRS). Brain structures were measured with regional gray matter (GM) volumes and tract-wise microstructural white matter (WM) integrity. Cognitive performance was evaluated with executive function, visuospatial function, reasoning, and memory. Sliding window analyses were performed to investigate age-related polygenic effects on brain structures, and mediation analyses tested whether structural changes mediated the gene–cognition relationship across different age groups. Analyses were replicated using two custom PRSs—one including APOE and the other excluding APOE regions—calculated with the clumping-and-thresholding approach. High AD-PRS was associated with accelerated GM atrophy (particularly in the hippocampus, thalamus, and parahippocampus), increased cerebral ventricular volume, and reduced WM integrity (especially in the fornix, cingulum, and superior fronto-occipital fasciculus). These polygenic effects demonstrated significant age-related amplification (pBonf < 0.05), with the strongest effects in individuals aged ≥ 75. Elevated AD-PRS was linked to lower cognitive performance across aging, especially in executive function, reasoning, and memory, which were significantly mediated by structural brain changes in subcortical and posterior limbic regions and their WM connections, predominantly in late aging (p < 0.05). Sensitivity analyses confirmed the robustness of these findings, emphasizing the dominant contribution of APOE, while also identifying age-specific effects from non-APOE variants. High polygenic risk for AD may be associated with accelerated cognitive decline in healthy aging, mediated by structural changes within hippocampal-thalamic regions and their connecting WM tracts. We provide insights into the early pathogenesis of AD and support the potential for age-targeted screening and early intervention for individuals at high genetic risk.
- 21 October 2025
- Published by Springer Nature in Genome Medicine
- Vol. 17 (1) , 1-14
Open AccessPolygenic risk for Alzheimer’s disease in healthy aging: age-related and APOE-driven effects on brain structures and cognition
Alzheimer’s disease (AD) is characterized by progressive neurodegeneration and cognitive decline with age. The genetic architecture of AD involves multiple loci, including the apolipoprotein E gene (APOE). The polygenic risk scores for AD (AD-PRS) provide a comprehensive genome-wide assessment of AD risk, yet their age-related effects on brain structures and cognitive function in cognitively unimpaired individuals remain largely undefined. We analyzed cognitively unimpaired, genetically unrelated Caucasians from the UK Biobank (N = 21,236, 64.5 ± 7.6 years). AD-PRS was derived using a Bayesian approach incorporating approximately 5 million genetic variants (UK Biobank’s standard PRS). Brain structures were measured with regional gray matter (GM) volumes and tract-wise microstructural white matter (WM) integrity. Cognitive performance was evaluated with executive function, visuospatial function, reasoning, and memory. Sliding window analyses were performed to investigate age-related polygenic effects on brain structures, and mediation analyses tested whether structural changes mediated the gene–cognition relationship across different age groups. Analyses were replicated using two custom PRSs—one including APOE and the other excluding APOE regions—calculated with the clumping-and-thresholding approach. High AD-PRS was associated with accelerated GM atrophy (particularly in the hippocampus, thalamus, and parahippocampus), increased cerebral ventricular volume, and reduced WM integrity (especially in the fornix, cingulum, and superior fronto-occipital fasciculus). These polygenic effects demonstrated significant age-related amplification (pBonf < 0.05), with the strongest effects in individuals aged ≥ 75. Elevated AD-PRS was linked to lower cognitive performance across aging, especially in executive function, reasoning, and memory, which were significantly mediated by structural brain changes in subcortical and posterior limbic regions and their WM connections, predominantly in late aging (p < 0.05). Sensitivity analyses confirmed the robustness of these findings, emphasizing the dominant contribution of APOE, while also identifying age-specific effects from non-APOE variants. High polygenic risk for AD may be associated with accelerated cognitive decline in healthy aging, mediated by structural changes within hippocampal-thalamic regions and their connecting WM tracts. We provide insights into the early pathogenesis of AD and support the potential for age-targeted screening and early intervention for individuals at high genetic risk.
- Top Cited PapersOpen Access
- 20 May 2025
- Published by Elsevier in Cell Reports Medicine
- Vol. 6 (5) , 102132
AI-powered integration of multimodal imaging in precision medicine for neuropsychiatric disorders
- 20 May 2025
- Published by Elsevier in Cell Reports Medicine
- Vol. 6 (5) , 102132
Top Cited PapersOpen AccessAI-powered integration of multimodal imaging in precision medicine for neuropsychiatric disorders
- Open Access
Heterogeneous ageing of brain networks across the Alzheimer’s disease continuum
Accelerated brain ageing has been implicated in Alzheimer’s disease (AD), which is shaped by genetic risk, molecular pathology, and disease processes. However, the spatial heterogeneity of brain ageing patterns across different functional networks along the AD continuum remained largely unexplored. In the present study, we developed a network-specific brain age prediction model trained on structural MRI from 28,341 healthy participants. By applying model to cross-sectional and longitudinal data from ADNI cohort, we estimated predicted age differences (PADs) and their change rates at individual level. Distinct network-specific brain ageing trajectories with disease progression were identified. Progressive MCI individuals showed early PAD deviations in the default mode network and accelerated changes in attention networks. Network-wise PAD dynamics mediated the effect of AD genetic risk and pathology on cognitive decline. Finally, integrating PAD features can improve predictive accuracy of MCI-to-AD conversion (AUC = 0.95). These findings highlight network-specific brain age PAD as sensitive biomarkers for early detection and monitoring of individualized AD risk.
Open AccessHeterogeneous ageing of brain networks across the Alzheimer’s disease continuum
Accelerated brain ageing has been implicated in Alzheimer’s disease (AD), which is shaped by genetic risk, molecular pathology, and disease processes. However, the spatial heterogeneity of brain ageing patterns across different functional networks along the AD continuum remained largely unexplored. In the present study, we developed a network-specific brain age prediction model trained on structural MRI from 28,341 healthy participants. By applying model to cross-sectional and longitudinal data from ADNI cohort, we estimated predicted age differences (PADs) and their change rates at individual level. Distinct network-specific brain ageing trajectories with disease progression were identified. Progressive MCI individuals showed early PAD deviations in the default mode network and accelerated changes in attention networks. Network-wise PAD dynamics mediated the effect of AD genetic risk and pathology on cognitive decline. Finally, integrating PAD features can improve predictive accuracy of MCI-to-AD conversion (AUC = 0.95). These findings highlight network-specific brain age PAD as sensitive biomarkers for early detection and monitoring of individualized AD risk.